Daily non-political popular news in brief.

Breast cancer patients may benefit from new accelerated treatment

Women with early-stage breast cancer may benefit from a new, accelerated approach to radiation therapy making their course of treatment shorter, according to a new study released today in the International Journal for Radiation Oncology*Biology*Physics, the official journal of ASTRO.

Read more »

Keywords: breast, cancer, patients, benefit, accelerated, treatment, patient

« Previous | Next »

Similar news on "Breast cancer patients may benefit from new accelerated treatment":

1. Molecular signature may identify cisplatin-sensitive breast tumors
   04-19-2007 · EurekAlert!
   Researchers at the Massachusetts General Hospital Cancer Center have identified a subgroup of hard-to-treat breast cancers that may be sensitive to the drug cisplatin, rarely used in the treatment of breast tumors. They also have discovered the molecular basis of this sensitivity, which may help identify patients most likely to benefit from cisplatin treatment.
   Similar news · Read more »
   
2. New radiation technique can greatly reduce painful skin burns in women with breast cancer
   11-06-2006 · EurekAlert!
   Breast cancer patients who undergo a new radiation technique called intensity modulated radiation therapy (IMRT) after surgery are three times less likely to have severe skin reactions from the treatment compared to standard radiation therapy, according to a study presented at the plenary session November 6, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia. The study is the first of its kind to show how recent dramatic improvements in radiation treatments directly benefit patients.
   Similar news · Read more »
   
3. MRI detects cancers missed by mammography in breast cancer patients
   06-02-2007 · EurekAlert!
   A unique examination of one treatment center's use of magnetic resonance imaging (MRI) in new breast cancer patients has found MRI to be superior to mammography in finding additional tumors in a breast in which cancer has already been diagnosed, and in detecting new tumors in a patient’s supposedly healthy breast.
   Similar news · Read more »
   
4. Exercise Helps Breast Cancer Patients Avoid Anemia
   10-09-2006 · ScienceDaily
   Women undergoing radiation treatment for breast cancer benefit from moderate intensity, regular aerobic activity, according to a new study. The study found that exercise improved the oxygen capacity of patients and maintained levels of red blood cells during radiation treatment.
   Similar news · Read more »
   
5. Research shows survival benefit for leukemia patients treated with arsenic trioxide
   06-04-2007 · EurekAlert!
   Through participation in a government-sponsored multi-year study, researchers at the Comprehensive Cancer Center at Wake Forest University have helped confirm that arsenic trioxide -- marketed as Trisenox -- significantly improves patient survival when coupled with standard chemotherapy treatment in newly diagnosed patients with acute promyelocytic leukemia, or APL.
   Similar news · Read more »
   
6. HER-2 status predicts success of chemotherapy in breast cancer treatment, study finds
   10-10-2007 · EurekAlert!
   Researchers have found they can potentially target chemotherapy for breast cancer to only those women most likely to benefit, sparing the majority of patients from unnecessary side effects.
   Similar news · Read more »
   
7. Anthracyclines improve survival in HER2-positive breast cancer patients
   12-25-2007 · EurekAlert!
   Treatment with the class of chemotherapy drugs called anthracyclines improves survival in women with HER2-positive breast cancer who have previously had surgery, but it may not offer any benefit for women with HER2-negative tumors, according to a study published online Dec. 25 in the Journal of the National Cancer Institute.
   Similar news · Read more »
   
8. Pre-treatment blood test could guide lung cancer therapy
   06-05-2007 · EurekAlert!
   A multi-center team, led by Vanderbilt-Ingram Cancer Center investigators, has developed a new pre-treatment blood test that predicts which non-small-cell lung cancer patients will live longer when they are treated with certain targeted cancer therapies (Iressa, Tarceva). The mass spectrometry-based test, described in the June 6 Journal of the National Cancer Institute, may allow physicians to select the most beneficial therapy for each lung cancer patient, a step forward in the era of personalized medicine.
   Similar news · Read more »
   
9. Rapid-acting insulin analogues in diabetes mellitus type 1 -- Superiority not proven
   07-17-2007 · EurekAlert!
   There is currently no evidence available of a superiority of rapid-acting insulin analogues over human insulin in the treatment of adult patients with diabetes mellitus type 1. The evidential value and design of studies available so far are inadequate and do not allow conclusions regarding most patient-relevant therapy goals, such as the reduction in long-term complications or overall mortality. Due to the lack of data, the benefit of rapid-acting insulin analogues in children and adolescents is unclear.
   Similar news · Read more »
   
10. Gene patenting -- steep cost for health care and patients
    05-07-2007 · EurekAlert!
    The drug trastuzumab (Herceptin) is used to treat HER2-positive breast cancer (a type of breast cancer that overexpresses the HER2 gene and accounts for about 25 percent of all breast cancers). Trastuzumab therapy improves the chances of survival; however, it has deleterious side effects and is expensive. Thus, it is important to accurately determine the patient's HER2 status.
    Similar news · Read more »